Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective.

Feby Savira,Bing Hui Wang,Andrew R Kompa,Zanfina Ademi,Alice J. Owen,Sophia Zoungas,Andrew Tonkin,Danny Liew,Ella Zomer

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective.

2020

Feby Savira
Bing Hui Wang
Andrew R Kompa
Zanfina Ademi
Alice J. Owen
Sophia Zoungas
Andrew Tonkin
Danny Liew
Ella Zomer

AimTo assess the cost-effectiveness of dapagliflozin in addition to standard care versus standard care alone in patients with chronic heart failure and reduced ejection fraction.MethodsA Markov mod...

Keywords:

in patient
standard care
Intensive care medicine
Health care
Physical therapy
Medicine
Heart failure
cost effectiveness
Dapagliflozin
Incremental cost-effectiveness ratio
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations